Pranob Bhattacharya, DrPH, MS, MBA, Vice President, Head of Oncology Clinical Operations at Astellas discusses the acceptance of the Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for regulatory review of zolbetuximab, for the potential first-line treatment of patients with certain types of gastric cancer.
Pranob Bhattacharya, DrPH, MS, MBA, is the Vice President, Head of Oncology Clinical Operations at Astellas. A global development leader and visionary with over 20 years of progressive experience, Pranob has had roles in Global Drug Development, Project Management, Global Operations, and participated in complex M&A, organizational & resource restructuring, and portfolio-level decision making. He has a proven track record of consistent successes in diverse drug development positions throughout his pharmaceutical career. Pranob also serves as MBA faculty specializing in Leadership programs.